We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Keep Reading →
March 29 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Keep Reading →
December 23 - Hedge Funds, News - Comments
Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers...
Keep Reading →
November 6 - Hedge Funds, News - Comments
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump. Both the S&P 500 and Russell 2000 delivered very...
Keep Reading →
July 5 - Hedge Funds, News - Comments
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which...
Keep Reading →
May 9 - Hedge Funds, News - Comments
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of...
Keep Reading →
December 18 - Hedge Funds, News - Comments
There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals...
Keep Reading →
March 14 - Hedge Funds, News - Comments
Bioscrip Inc. (NASDAQ:BIOS): Philip Hempleman’s Ardsley Partners filed an amended 13D. You can check out Ardsley Partners’ latest holdings...
Keep Reading →
January 26 - Hedge Funds - Comments
Bioscrip Inc. (NASDAQ:BIOS): Jeffrey Bersh And Michael Wartell’s Venor Capital Management filed an amended 13D. You can check out Venor Capital...
Keep Reading →
November 8 - Hedge Funds - Comments
Bioscrip Inc. (NASDAQ:BIOS): Christopher Shackelton And Adam Gray’s Coliseum Capital filed an amended 13D. You can check out Coliseum Capital’...
Keep Reading →
September 11 - Hedge Funds - Comments
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that...
Keep Reading →
September 1 - Lists, News - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
August 21 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 17 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington...
Keep Reading →
August 14 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 17 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington...
Keep Reading →
July 14 - Hedge Funds - Comments
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down...
Keep Reading →
December 14 - Hedge Funds, News - Comments
In my “Technically Speaking” analyses, I’ll take a look at up to three stocks that have entered into either an overbought or oversold...
Keep Reading →
November 9 - News, Stock Analysis - Comments
Billionaire Mario Gabelli‘s GAMCO Investors recently filed an amended Form 13D with the US Securities and Exchange Commission, in which it reported...
Keep Reading →
October 19 - Hedge Funds, News - Comments
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk...
Keep Reading →
October 8 - Hedge Funds, News - Comments
Coliseum Capital, managed by Christopher Shackelton and Adam Gray, has recently disclosed an increase in its holding of BioScrip Inc (NASDAQ:BIOS). According...
Keep Reading →
June 26 - Hedge Funds, News - Comments
Corporate insiders, namely executives and Board members, are usually privy to a great deal of up-to-date information about current developments or future...
Keep Reading →
June 21 - Insider Trading, News - Comments
With the markets on edge over a potential Brexit and the FOMC meeting scheduled for this week, the coming days may be more volatile than expected. Among...
Keep Reading →
June 13 - Market Movers, News - Comments
Brian Newman and David Heller’s Cloud Gate Capital, one of the newest additions to our database of more than 700 top hedge funds, was a big winner on...
Keep Reading →
April 1 - Hedge Funds, News - Comments
Christopher Shackelton and Adam Gray’s Coliseum Capital initiated a new position in BioScrip Inc (NASDAQ:BIOS), according to a recent 13D filing...
Keep Reading →
March 20 - Hedge Funds, News - Comments
Ken Griffin’s Citadel Investment Group disclosed a large purchase in Rosetta Resources (NASDAQ:ROSE) this week. According to the 13G Form filed with...
Keep Reading →
February 10 - Hedge Funds, News - Comments
GAMCO Investors and other funds managed by Mario Gabelli continue to aggressively add to their holdings in BioScrip Inc (NASDAQ:BIOS), having increased...
Keep Reading →
January 28 - Hedge Funds, News - Comments
Mario Gabelli’s GAMCO Investors and James E. Flynn’s Deerfield Management seem bullish on BioScrip Inc (NASDAQ:BIOS) and Proteon Therapeutics Inc (...
Keep Reading →
October 27 - Hedge Funds, News - Comments
A few days ago, Phil Frohlich’s Prescott Group Capital Management filed its 13F for the second quarter of 2014. In this document, the hedge fund disclosed...
Keep Reading →
July 23 - Hedge Funds, News - Comments
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD. The firm usually invests in the lower...
Keep Reading →
May 27 - Hedge Funds, News - Comments
In another round of filing with the Securities and Exchange Commission, Mario Gabelli has revealed his latest moves. Together with GAMCO Investors and...
Keep Reading →
April 2 - Hedge Funds, News - Comments
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last...
Keep Reading →
February 13 - Hedge Funds, News - Comments
Alan Fournier‘s hedge fund, Pennant Capital Management, reported in a new filing boosting its exposure at BioScrip Inc (NASDAQ:BIOS) to some 5.74...
Keep Reading →
November 8 - Hedge Funds, News - Comments
Is Rite Aid Corporation (NYSE:RAD) a good investment? To the average investor, there are many methods market participants can use to watch their holdings...
Keep Reading →
August 29 - News - Comments
At the moment, there are tons of methods market participants can use to track publicly traded companies. Two of the most innovative are hedge fund and...
Keep Reading →
August 26 - News - Comments
In today’s marketplace, there are many gauges investors can use to monitor the equity markets. Some of the most under-the-radar are hedge fund and insider...
Keep Reading →
August 23 - News - Comments
BioScrip Inc. (NASDAQ:BIOS) was in 16 hedge funds’ portfolio at the end of the first quarter of 2013. BIOS investors should pay attention to an...
Keep Reading →
June 10 - News - Comments
PharMerica Corporation (NYSE:PMC) shareholders have witnessed an increase in hedge fund interest in recent months. In the financial world, there are plenty...
Keep Reading →
June 7 - News - Comments
Walgreen Company (NYSE:WAG) was in 52 hedge funds’ portfolio at the end of the first quarter of 2013. WAG shareholders have witnessed a decrease...
Keep Reading →
May 24 - News - Comments
Is CVS Caremark Corporation (NYSE:CVS) an outstanding investment right now? The smart money is getting less optimistic. The number of bullish hedge fund...
Keep Reading →
May 23 - News - Comments
BioScrip Inc. (NASDAQ:BIOS) was in 11 hedge funds’ portfolio at the end of December. BIOS investors should be aware of a decrease in hedge fund...
Keep Reading →
April 12 - News - Comments